Mesa Laboratories Statistics
Total Valuation
MLAB has a market cap or net worth of $525.42 million. The enterprise value is $665.68 million.
| Market Cap | 525.42M |
| Enterprise Value | 665.68M |
Important Dates
The next estimated earnings date is Tuesday, August 4, 2026, before market open.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | May 29, 2026 |
Share Statistics
MLAB has 5.52 million shares outstanding. The number of shares has increased by 2.66% in one year.
| Current Share Class | 5.52M |
| Shares Outstanding | 5.52M |
| Shares Change (YoY) | +2.66% |
| Shares Change (QoQ) | -0.38% |
| Owned by Insiders (%) | 3.27% |
| Owned by Institutions (%) | 87.82% |
| Float | 4.94M |
Valuation Ratios
The trailing PE ratio is 78.60 and the forward PE ratio is 69.93.
| PE Ratio | 78.60 |
| Forward PE | 69.93 |
| PS Ratio | 2.11 |
| Forward PS | 2.03 |
| PB Ratio | 2.82 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 13.27 |
| P/OCF Ratio | 12.27 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.93, with an EV/FCF ratio of 16.82.
| EV / Earnings | 99.18 |
| EV / Sales | 2.67 |
| EV / EBITDA | 15.93 |
| EV / EBIT | 35.96 |
| EV / FCF | 16.82 |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.91.
| Current Ratio | 1.72 |
| Quick Ratio | 1.17 |
| Debt / Equity | 0.91 |
| Debt / EBITDA | 3.45 |
| Debt / FCF | 4.27 |
| Interest Coverage | 1.73 |
Financial Efficiency
Return on equity (ROE) is 3.88% and return on invested capital (ROIC) is 3.17%.
| Return on Equity (ROE) | 3.88% |
| Return on Assets (ROA) | 2.69% |
| Return on Invested Capital (ROIC) | 3.17% |
| Return on Capital Employed (ROCE) | 5.06% |
| Weighted Average Cost of Capital (WACC) | 7.94% |
| Revenue Per Employee | $347,462 |
| Profits Per Employee | $9,361 |
| Employee Count | 717 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 3.51 |
Taxes
In the past 12 months, MLAB has paid $5.30 million in taxes.
| Income Tax | 5.30M |
| Effective Tax Rate | 44.13% |
Stock Price Statistics
The stock price has increased by +2.56% in the last 52 weeks. The beta is 0.93, so MLAB's price volatility has been similar to the market average.
| Beta (5Y) | 0.93 |
| 52-Week Price Change | +2.56% |
| 50-Day Moving Average | 101.99 |
| 200-Day Moving Average | 84.97 |
| Relative Strength Index (RSI) | 40.30 |
| Average Volume (20 Days) | 255,095 |
Short Selling Information
The latest short interest is 279,822, so 5.06% of the outstanding shares have been sold short.
| Short Interest | 279,822 |
| Short Previous Month | 232,139 |
| Short % of Shares Out | 5.06% |
| Short % of Float | 5.67% |
| Short Ratio (days to cover) | 1.65 |
Income Statement
In the last 12 months, MLAB had revenue of $249.13 million and earned $6.71 million in profits. Earnings per share was $1.21.
| Revenue | 249.13M |
| Gross Profit | 158.27M |
| Operating Income | 18.51M |
| Pretax Income | 12.01M |
| Net Income | 6.71M |
| EBITDA | 41.78M |
| EBIT | 18.51M |
| Earnings Per Share (EPS) | $1.21 |
Balance Sheet
The company has $28.57 million in cash and $168.83 million in debt, with a net cash position of -$140.26 million or -$25.39 per share.
| Cash & Cash Equivalents | 28.57M |
| Total Debt | 168.83M |
| Net Cash | -140.26M |
| Net Cash Per Share | -$25.39 |
| Equity (Book Value) | 186.25M |
| Book Value Per Share | 33.71 |
| Working Capital | 44.37M |
Cash Flow
In the last 12 months, operating cash flow was $42.83 million and capital expenditures -$3.25 million, giving a free cash flow of $39.58 million.
| Operating Cash Flow | 42.83M |
| Capital Expenditures | -3.25M |
| Depreciation & Amortization | 23.27M |
| Net Borrowing | -26.75M |
| Free Cash Flow | 39.58M |
| FCF Per Share | $7.16 |
Margins
Gross margin is 63.53%, with operating and profit margins of 7.43% and 2.69%.
| Gross Margin | 63.53% |
| Operating Margin | 7.43% |
| Pretax Margin | 4.82% |
| Profit Margin | 2.69% |
| EBITDA Margin | 16.77% |
| EBIT Margin | 7.43% |
| FCF Margin | 15.89% |
Dividends & Yields
This stock pays an annual dividend of $0.64, which amounts to a dividend yield of 0.67%.
| Dividend Per Share | $0.64 |
| Dividend Yield | 0.67% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 52.89% |
| Buyback Yield | -2.66% |
| Shareholder Yield | -1.98% |
| Earnings Yield | 1.28% |
| FCF Yield | 7.53% |
Analyst Forecast
The average price target for MLAB is $112.00, which is 17.77% higher than the current price. The consensus rating is "Buy".
| Price Target | $112.00 |
| Price Target Difference | 17.77% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MLAB has an Altman Z-Score of 1.41 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.41 |
| Piotroski F-Score | 7 |